News QuidelOrtho Corporation

Equities

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 18/11/2025 GMT			5-day change	1st Jan Change
21.28 ^USD	+0.85%		-2.79%	-52.23%

11-06	UBS Adjusts Price Target on QuidelOrtho to $31 From $26, Maintains Neutral Rating	MT
11-06	QuidelOrtho Corporation, Q3 2025 Earnings Call, Nov 05, 2025

UBS Adjusts Price Target on QuidelOrtho to $31 From $26, Maintains Neutral Rating	11-06	MT
QuidelOrtho Corporation, Q3 2025 Earnings Call, Nov 05, 2025	11-06
In vitro diagnostics firm QuidelOrtho beats Q3 revenue expectations	11-05	RE
QuidelOrtho: Q3 Earnings Snapshot	11-05	AQ
Earnings Flash (QDEL) QuidelOrtho Corporation Reports Q3 Revenue $699.9M, vs. FactSet Est of $664.9M	11-05	MT
Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q3 Adjusted EPS $0.80 per Share, vs. FactSet Est of $0.46	11-05	MT
QuidelOrtho Reports Third Quarter 2025 Financial Results	11-05	PR
QuidelOrtho Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 28, 2025	11-05	CI
Quidelortho Corporation Provides Earnings Guidance for Full Year 2025	11-05	CI
QuidelOrtho Receives FDA 510(k) Clearance for VITROS?? Immunodiagnostic Products hs Troponin I Assay	11-03	CI
QuidelOrtho Gets FDA Clearance for Cardiac Assay	11-03	MT
Quidelortho receives FDA 510(k) clearance for VITROS Immunodiagnostic Products hs Troponin I assay	11-03	RE
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay	11-03	PR
QuidelOrtho to Report Third Quarter 2025 Financial Results	10-22	PR
Citigroup Downgrades QuidelOrtho to Neutral From Buy, Adjusts Price Target to $33 From $40	10-07	MT
QuidelOrtho Announces Availability of QUICKVUE Influenza + SARS Test for Professional Use	09-23	AQ
QuidelOrtho Corporation Announces Availability of QuICKVUE Influenza + SARS Test for Professional Use	09-22	CI
QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use	09-22	PR
RBC Raises Price Target on QuidelOrtho to $62 From $60, Keeps Outperform Rating	09-03	MT
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference	08-28	PR
QuidelOrtho completes debt refinancing	08-21	RE
QuidelOrtho Completes $3.4 Billion in Debt Refinancing	08-21	MT
QuidelOrtho Corporation Enters into a Credit Agreement	08-21	CI
QuidelOrtho Completes Debt Refinancing	08-21	PR
Quidelortho welcomes Erich Wolff as EVP, strategy & corporate development	08-19	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News QuidelOrtho Corporation

Equities

QDEL

US2197981051

Advanced Medical Equipment & Technology

Filters